Insider Selling: Afya (NASDAQ:AFYA) Insider Sells $55,341.30 in Stock

Afya Limited (NASDAQ:AFYA) insider Santos Welder Ferreira sold 4,161 shares of the business’s stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $13.30, for a total transaction of $55,341.30. Following the sale, the insider directly owned 35,000 shares in the company, valued at $465,500. The trade was a 10.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Afya Trading Up 1.8%

Shares of NASDAQ AFYA opened at $14.15 on Friday. The stock has a market cap of $1.33 billion, a P/E ratio of 8.63, a price-to-earnings-growth ratio of 1.56 and a beta of 0.34. The firm has a 50 day moving average price of $13.76 and a two-hundred day moving average price of $14.25. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.20 and a current ratio of 2.20. Afya Limited has a 52-week low of $11.62 and a 52-week high of $16.16.

Afya (NASDAQ:AFYA) last posted its quarterly earnings data on Friday, August 14th. The company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03. The business had revenue of $187.80 million during the quarter, compared to the consensus estimate of $189.62 million. Afya had a return on equity of 17.58% and a net margin of 20.55%. As a group, equities analysts forecast that Afya Limited will post 1.86 EPS for the current year.

Wall Street Analyst Weigh In

AFYA has been the subject of several analyst reports. Bradesco Corretora upgraded shares of Afya to an “outperform” rating and set a $17.00 price target for the company in a report on Thursday, September 24th. Bank of America reaffirmed a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. Weiss Ratings cut shares of Afya from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, July 31st. Zacks Research raised shares of Afya from a “strong sell” rating to a “hold” rating in a research note on Monday. Finally, JPMorgan Chase & Co. upgraded shares of Afya from a “neutral” rating to an “overweight” rating and dropped their target price for the company from $21.00 to $19.00 in a report on Wednesday. Two research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $17.25.

Hedge Funds Weigh In On Afya

Institutional investors have recently added to or reduced their stakes in the business. Public Employees Retirement System of Ohio acquired a new stake in shares of Afya during the 2nd quarter worth approximately $67,000. Engineers Gate Manager LP acquired a new position in shares of Afya during the 2nd quarter valued at $325,000. Finally, Banco BTG Pactual S.A. bought a new position in Afya during the fourth quarter worth $462,000. 88.02% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Afya

Here are the key news stories impacting Afya this week:

• Positive Sentiment: JPMorgan upgraded Afya (AFYA) from Neutral to Overweight, citing a more favorable outlook and assigning a $19 price target. The target remains well above recent trading levels, implying substantial potential upside, despite being reduced from $21. JPMorgan Upgrades Afya to Overweight From Neutral, $19 Price Target
• Positive Sentiment: Value-focused coverage highlighted Afya as a potentially attractive investment based on its low valuation. The company trades at a relatively modest earnings multiple, while its latest quarterly EPS exceeded analyst expectations, supporting the case for continued investor interest. GF Value Says Afya Is Undervalued
• Neutral Sentiment: Zacks Research raised Afya’s rating from Strong Sell to Hold. The improvement reduces a prior negative signal but does not represent a bullish recommendation. A separate Zacks comparison of Afya and Universal Technical Institute also focused on relative value rather than introducing a company-specific catalyst. Afya Stock Moved Up to Hold by Zacks Research
• Negative Sentiment: Insider Santos Welder Ferreira sold 4,161 shares for approximately $55,341, reducing his direct stake by 10.63%. Although the sale is relatively small compared with Afya’s market value, insider selling can weigh on sentiment and partially offsets the benefit of JPMorgan’s upgrade. Afya Insider Selling

About Afya

Afya Limited (NASDAQ: AFYA) is a Brazil-based medical education and health technology company. The company provides education and professional development for physicians and other healthcare professionals, with activities spanning undergraduate medical programs, medical residency preparation, specialization courses, continuing medical education and digital learning services.

Afya also develops technology-enabled products designed to support healthcare professionals throughout their careers.